Skip to content
Popular Searches
  • # Cancer
  • # Alzheimer's
  • # DNA
  • # FDA
  • # Diabetes
  • # COVID19
  • linkedin
  • facebook
  • instagram
  • twitter
Home BiotechReality – Covering Industry, Business, and Academia

Explore the frontiers of Biotechnology, Pharma/Biopharma industry and Science with BiotechReality. We publish news, reports, views and articles.

  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
Trending

Trending

Antibiotics: Mode of Action and Types

30 September 2023

Scientists discovered infectious H5N1 Influenza Virus in raw milk rapidly declines with heat treatment

17 June 2024

Salmonella and Food Poisoning – Salmonellosis

11 November 2023

Healthy brains may depend on a common marker of neurological diseases

11 January 2024

Researchers map fifty thousand of the human genome’s cryptic “knots” of DNA

1 September 2024

Discovery of bacteria that can destroy Forever Chemicals

20 July 2024

An important development in “smart cell” design

5 January 2025

Amyotrophic Lateral Sclerosis Can be Diagnosed With Blood Test

27 February 2025

AbbVie Enters Into the Obesity Drug Market With a License Agreement

5 March 2025

“Healthy Skepticism” A New Ad Campaign from Lilly Against Compounded Drugs

2 March 2025

Researchers Developed a Transparent Brain Implant That Can Monitor Surface-Based Neural Activity

17 January 2024

A Novel Method for Forecasting Drug Resistance in Malaria

11 December 2024

Pirtobrutinib

Based on Results From the Phase 3 BRUIN CLL-321 trial, Lilly’s Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union
Business Clinical Trials News Regulatory Approval

Based on Results From the Phase 3 BRUIN CLL-321 trial, Lilly’s Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union

Editor's Desk 1 March 2025

The European Commission is currently taking final action on the application for the use of Jaypirca in patients with relapsed or refractory CLL who have received prior treatment with a BTK inhibitor as a result of this favorable view.

Areas Covered

  • Anti-obesity Drugs
  • Applications of Biotechnology
  • Artificial Intelligence
  • Astrobiology
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • Cell Biology
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Life Sciences
  • Machine Learning
  • Medical Devices
  • Mental Health
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Pharmacology
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Staining
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs
Market Analysis
Publish on BiotechReality

  • Novo Nordisk Hiring Senior Regulatory Affairs Specialist in Seoul, South Korea – May 2025
  • Pfizer Hiring an IT Senior Associate in Chennai, India – April, 2025
  • IQVIA Hiring Clinical Data Specialist in Cochin, India – April 2025
  • Amgen Hiring CRM Engineer (Veeva/Salesforce) in Hyderabad, India – April, 2025
  • Principle Machine Learning Scientist – Molecular AI – Novo Nordisk
SciRealityPress BiotechReality

A SciRealityPress Associate

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2025
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinuePrivacy policy